AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments. The company offers sleep therapy equipment, supplies, and related services, such as continuous positive airway pressure and BiLevel services to individuals suffering from obstructive sleep apnea; oxygen and home mechanical ventilation equipment and supplies and related chronic therapy services; and medical devices, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; and other HME devices and supplies. It also provides PAP machines, wheelchairs, hospital beds, oxygen concentrators, ventilators, insulin pumps, diabetes management and wound care supplies, orthopedic bracing, breast pumps and supplies, walkers, commodes, enteral supplies, and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. was founded in 2012 and is headquartered in Conshohocken, Pennsylvania.…
Has AdaptHealth (AHCO) Fallen Far Enough To Look Like A Bargain?
AdaptHealth (NASDAQ: AHCO) is listed on Nasdaq, where its shares trade in USD. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 10,900 employees.
The shares were at 7.200 USD on 20 November 2026, down 30.4% over 52 weeks. Its 52-week range is 5.210 USD to 13.43 USD: the price is 46.4% below the high and 38.2% above the low.
Its market capitalisation is 982.98M USD.
AdaptHealth reports return on equity of -4.7%, an operating margin of 3.8% and revenue up 10.9% year over year.
Its debt exceeds its cash by 1.97B USD, a debt-to-equity ratio of 1.25. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 7 analysts cover the stock; their mean price target of 8.857 USD is 23.0% above the current price. The next earnings report is expected on 23 February 2027.